Pricing
  1. US-listed companies
  2. IDEXX LABORATORIES INC
  3. Financials
  4. Diluted EPS

IDEXX LABORATORIES INC (IDXX)

Market cap
$45.8B
P/E ratio
SummaryFinancials
Period EndDiluted EPS (USD)YoY (%)
Dec 31, 202410.7+6.06%
Dec 31, 202310.1+25.28%
Dec 31, 20228-6.63%
Dec 31, 20218.6+28.17%
Dec 31, 20206.7+37.22%
Dec 31, 20194.9+14.79%
Dec 31, 20184.3+44.90%
Dec 31, 20172.9+20.49%
Dec 31, 20162.4+19.02%
Dec 31, 20152.1-42.74%
Dec 31, 20143.6+2.87%
Dec 31, 20133.5+9.78%
Dec 31, 20123.2+33.76%
Dec 31, 20102.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat